In view of the role of sEVs in mediating cancer progression and metastasis, we treated MDA/vec and MDA/MGAT3 cells with GW4869, a N‐SMase2 inhibitor that blocks ceramide‐mediated release of sEVs (Trajkovic et al., 2008). Here, SMPD3 is linked to cancer.